| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031170821 |
| P356 | DOI | 10.1046/J.1523-1755.2002.00668.X |
| P698 | PubMed publication ID | 12427154 |
| P2093 | author name string | Sundaram Hariharan | |
| Ashwani Khanna | |||
| Barbara Bresnahan | |||
| Matthew Plummer | |||
| Cathy Bromberek | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 2257-2263 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity | |
| P478 | volume | 62 |
| Q38783647 | A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation |
| Q58106881 | A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol |
| Q46873896 | Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression |
| Q53482976 | Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. |
| Q37064446 | Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. |
| Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
| Q80347440 | Cardiac transplantation and cyclosporine nephrotoxicity |
| Q36062030 | Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens |
| Q34217266 | Crosstalk between Smad and Mitogen-Activated Protein Kinases for the Regulation of Apoptosis in Cyclosporine A- Induced Renal Tubular Injury |
| Q35906315 | Current and future immunosuppressive strategies in renal transplantation |
| Q94359946 | Cyclosporine nephrotoxicity |
| Q79819468 | Cyclosporine nephrotoxicity |
| Q54668270 | Cytokines and chemokine gene expression in human kidney transplantation. |
| Q45100299 | De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. |
| Q37806767 | Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach. |
| Q83974853 | Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model |
| Q43241185 | Electrolyte free water clearance could be an early sign of renal dysfunction in renal transplant patients |
| Q50059461 | Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation |
| Q46866824 | Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. |
| Q41855731 | Encapsulating peritoneal sclerosis in liver transplant recipients: a report of 2 cases |
| Q58326620 | Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis |
| Q34816520 | Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease. |
| Q30405394 | Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction |
| Q37229944 | Experience with tacrolimus in children with steroid-resistant nephrotic syndrome |
| Q61801800 | Gene networking in colistin-induced nephrotoxicity reveals an adverse outcome pathway triggered by proteotoxic stress |
| Q34110645 | Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study. |
| Q90016261 | Immunosuppressant drug tacrolimus induced mitochondrial nephrotoxicity, modified PCNA and Bcl-2 expression attenuated by Ocimum basilicum L. in CD1 mice |
| Q51161846 | Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients. |
| Q82888086 | Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats |
| Q90474075 | Kidney allograft fibrosis: what we learned from latest translational research studies |
| Q85028213 | Magnesium-deficiency does not alter calcineurin inhibitors activity in mice |
| Q46452689 | Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis. |
| Q89702114 | Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology |
| Q33989902 | PharmGKB summary: cyclosporine and tacrolimus pathways |
| Q38435024 | Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients |
| Q35710811 | Pharmacology of calcineurin antagonists |
| Q45058830 | Plasma TGF-beta1 as a risk factor for gingival overgrowth. |
| Q36155845 | Progressive chronic kidney disease after pediatric lung transplantation |
| Q54324332 | Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. |
| Q34289498 | Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation |
| Q92617913 | Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients |
| Q87289809 | Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation |
| Q37712090 | Sclerosing Encapsulated Peritonitis: A devastating and infrequent disease complicating kidney transplantation, case report and literature review |
| Q46452695 | Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients. |
| Q38774503 | Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells |
| Q35166453 | Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling |
| Q33263272 | Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activation |
| Q34564959 | Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. |
| Q93010157 | The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept |
| Q36577612 | The challenge of renal function in heart transplant children |
| Q50922246 | The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients. |
| Q38578386 | The safety of calcineurin inhibitors for kidney-transplant patients |
| Q35680649 | Therapeutic potential of macrolide immunosuppressants in dermatology |
| Q53638795 | mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience. |
Search more.